Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor–α Inhibitors | Zendy

Russell D. Bradford | Zendy; April C. Pettit | Zendy; Patty W. Wright | Zendy; Mark J. Mulligan | Zendy; Larry W. Moreland | Zendy; David McLain | Zendy; John W. Gnann | Zendy; Karen C. Bloch | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Herpes Simplex Encephalitis during Treatment with Tumor Necrosis Factor–α Inhibitors

Author(s) -

Russell D. Bradford,

April C. Pettit,

Patty W. Wright,

Mark J. Mulligan,

Larry W. Moreland,

David McLain,

John W. Gnann,

Karen C. Bloch

Publication year - 2009

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/605498

Subject(s) - medicine , encephalitis , herpes simplex virus , tumor necrosis factor alpha , virology , tumor necrosis factor α , immunology , viral encephalitis , virus , alphaherpesvirinae , necrosis , herpesviridae , viral disease

We report 3 cases of herpes simplex virus encephalitis in patients receiving tumor necrosis factor-alpha (TNF-alpha) inhibitors for rheumatologic disorders. Although TNF-alpha inhibitors have been reported to increase the risk of other infectious diseases, to our knowledge, an association between anti-TNF-alpha drugs and herpes simplex virus encephalitis has not been previously described.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research